A recent study indicates that individuals who discontinue new slimming jabs like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt traditional diet and exercise plans.
Published data in a prominent medical journal points out that while obese people often shed substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs must be aware of the potential of fast rebound weight gain when the therapy ends," stated lead investigator Dr. Susan Jebb.
Such speed of regain suggests a return to starting mass within about one and a half years.
Weighing Therapies
The research, which examined 37 of studies involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.
Researchers note that people who shed pounds through dieting generally have a more gradual creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Regain
Nutrition scientists suggest the way of the injections explains the heightened weight return.
GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal might result in the system to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making overeating a significant risk."
A Chronic Issue?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Professionals contend that, given the high risk of relapse, the therapy should be considered life-long.
This perspective is echoed by pharmaceutical companies, who say that the findings "emphasize the persistent nature of obesity," similar to managing diseases like diabetes.
User Accounts
People who have stopped the medication describe a intense resurgence of appetite.
"I experienced a trigger flipping and I was suddenly extremely hungry," said a patient.
This challenge is compounded if users have not established lasting lifestyle or habit changes during treatment.
Growing Adoption
Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with interest continuing to grow.
- Adoption is greater among women compared to men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, researchers caution that while GLP-1 drugs are effective agents for weight loss, they are not a magic solution and maintained weight loss likely depends on combined lifestyle changes.
